
Glucose is, under normal conditions, virtually the sole substrate supporting
the intense energy metabolism required for brain function. Hexokinase catalyzes
the initial step in metabolism of glucose, and regulation of hexokinase activity
is generally recognized as a major factor governing the rate of cerebral glucose
metabolism. How hexokinase is regulated, with activity increased during periods
of increased neurophysiological activity and decreased when energy demands
subside, is the focus of our research. This regulation is complex. Classical
allosteric inhibition by the product, glucose 6-phosphate, is undoubtedly a
factor. However, hexokinase binds to the outer mitochondrial membrane and there
is clear evidence that this physical association leads to close metabolic
interactions with intramitochondrial oxidative phosphorylation, and that this is
also of regulatory significance.
We are interested in the molecular basis for
interaction of hexokinase with mitochondria, and for the resultant close
coupling of glucose phosphorylating activity with intramitochondrial ATP
production. The levels of hexokinase vary markedly in different brain regions,
and are generally correlated with basal levels of glucose utilization. Chronic
perturbations of neurophysiological function result in altered rates of glucose
utilization and hexokinase activity in the affected region. There is
reason to believe that this is, at least partly, due to regulation at the
transcriptional level, and hence we are involved in characterization of the
elements regulating the transcription of this gene. While our major focus is on
the Type I isozyme of hexokinase, the predominant form in brain, we have a
general interest in the structure and function of other mammalian hexokinases,
particularly the Type II and Type III isozymes. We are interested in the
comparative enzymology of the hexokinase isozymes, and in defining their unique
roles in cellular metabolism. All of this requires a synthesis of information
gained from studies employing techniques of enzymology, molecular biology,
membrane biochemistry, and neurochemistry.
Sui DX, Wilson JE. (2004) Selective depletion of the Type I, Type II, and Type III isozymes of hexokinase in mammalian cells using small interfering RNAs. Biochemical And Biophysical Research Communications 319 (3): 768-773.
Cesar MD, Wilson JE. (2004) All three isoforms of the voltage-dependent anion channel (VDAC1, VDAC2, and VDAC3) are present in mitochondria from bovine, rabbit, and rat brain. Archives Of Biochemistry And Biophysics, 422 (2): 191-196.
Wilson JE. (2003) Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. Journal Of Experimental Biology, 206 (12): 2049-2057.
Sui DX, Wilson JE. (2002) Functional interactions between the noncovalently associated N- and C-terminal halves of mammalian Type I hexokinase. Archives Of Biochemistry And Biophysics, 401 (1): 21-28.
Hashimoto M, Wilson JE. (2002) Kinetic and regulatory properties of HKI+, a modified form of the type I isozyme of mammalian hexokinase in which interactions between the N- and C-terminal halves have been disrupted. Archives Of Biochemistry And Biophysics, 399 (1): 109-115.
Sui, D., and Wilson, J.E. (2001) Purification of the Type II and Type III
isozymes of rat hexokinase, expressed in yeast. Prot. Exp. Purif., 24(1):83-9.
Sebastian, S., Edassery, S., and Wilson, J.E. (2001) The human
gene for the Type III isozyme of hexokinase: Structure, basal promoter, and
evolution. Arch. Biochem. Biophys. , 395(1):113-20.
de Cerqueira Cesar, M., and Wilson, J.E. (2001) Functional
characteristics of hexokinase bound to the Type A and Type B sites of bovine
brain mitochondria. Arch. Biochem. Biophys., 397(1):106-12.
Hashimoto, M., and Wilson, J.E. (2000) Membrane
potential-dependent conformational changes in mitochondrially-bound hexokinase
of brain. Arch. Biochem. Biophys. 384, 163-173.